Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2011 Jul 23;9(10):902–909.e1. doi: 10.1016/j.cgh.2011.07.006

Table 2.

Multivariate analysis of variables associated with MDB gain and MDB loss.

Variable OR 95% Cl P value
MDB Gain (n=719)
 Female 1.88 1.06–3.34 0.031
 Hispanic 2.94 1.28–6.77 0.011
 Presence of diabetes 2.28 1.26–4.13 0.006
 Fibrosis, baseline 1.03 0.78–1.35 0.84
 Fibrosis, follow-up 1.84 1.39–2.43 <0.001
 Steatosis, baseline 0.93 0.63–1.37 0.71
 Steatosis, follow-up 2.14 1.33–3.44 0.002
MDB Loss (n=125)
 Absence of diabetes 5.21 1.24–21.9 0.024
 Non-smoker 8.96 2.20–38.7 0.003
 Fibrosis, baseline 0.59 0.32–1.10 0.097
 Fibrosis, follow up 0.93 0.54–1.60 0.80
 BMI, baseline (kg/m2) 1.00 0.86–1.18 0.92
 Weight change 0.98 0.94–1.01 0.37

Model includes variables significant in univariate analysis.